178 related articles for article (PubMed ID: 30073931)
21. Assessment of late cardiotoxicity of pirarubicin (THP) in children with acute lymphoblastic leukemia.
Shimomura Y; Baba R; Watanabe A; Horikoshi Y; Asami K; Hyakuna N; Iwai A; Matsushita T; Yamaji K; Hori T; Tsurusawa M;
Pediatr Blood Cancer; 2011 Sep; 57(3):461-6. PubMed ID: 21298773
[TBL] [Abstract][Full Text] [Related]
22. Cardiotoxicity evaluation in pediatric patients with acute lymphoblastic leukemia - results of prospective study.
Radu LE; Ghiorghiu I; Oprescu A; Dorobantu D; Arion C; Colita A
Med Ultrason; 2019 Nov; 21(4):449-455. PubMed ID: 31765454
[TBL] [Abstract][Full Text] [Related]
23. Protective effects of Panax ginseng against doxorubicin-induced cardiac toxicity in patients with non-metastatic breast cancer: A randomized, double-blind, placebo-controlled clinical trial.
Hamidian M; Foroughinia F; Haghighat S; Attar A; Haem E
J Oncol Pharm Pract; 2023 Sep; 29(6):1306-1316. PubMed ID: 35975564
[TBL] [Abstract][Full Text] [Related]
24. Late cardiac effects of doxorubicin therapy for acute lymphoblastic leukemia in childhood.
Lipshultz SE; Colan SD; Gelber RD; Perez-Atayde AR; Sallan SE; Sanders SP
N Engl J Med; 1991 Mar; 324(12):808-15. PubMed ID: 1997853
[TBL] [Abstract][Full Text] [Related]
25. Role of ACE inhibitors in anthracycline-induced cardiotoxicity: A randomized, double-blind, placebo-controlled trial.
Gupta V; Kumar Singh S; Agrawal V; Bali Singh T
Pediatr Blood Cancer; 2018 Nov; 65(11):e27308. PubMed ID: 30009543
[TBL] [Abstract][Full Text] [Related]
26. Diazoxide protects against doxorubicin-induced cardiotoxicity in the rat.
Hole LD; Larsen TH; Fossan KO; Limé F; Schjøtt J
BMC Pharmacol Toxicol; 2014 May; 15():28. PubMed ID: 24887454
[TBL] [Abstract][Full Text] [Related]
27. [Echocardiographic assessment of circulation system in patients during and 3-5 years after all therapy in childhood].
Ostański M; Sońta-Jakimczyk D
Wiad Lek; 2002; 55(3-4):164-73. PubMed ID: 12182001
[TBL] [Abstract][Full Text] [Related]
28. The evaluation of doxorubicin-induced cardiotoxicity: comparison of Doppler and tissue Doppler-derived myocardial performance index.
Ayhan SS; Özdemir K; Kayrak M; Bacaksiz A; Vatankulu MA; Eren Ö; Koc F; Duman C; Gülec H; Demir K; Ari H; Sönmez O; Gök H
Cardiol J; 2012; 19(4):363-8. PubMed ID: 22825896
[TBL] [Abstract][Full Text] [Related]
29. Association of genetic polymorphisms NCF4 rs1883112, CBR3 rs1056892, and ABCC1 rs3743527 with the cardiotoxic effects of doxorubicin in children with acute lymphoblastic leukemia.
Gándara-Mireles JA; Lares-Asseff I; Reyes Espinoza EA; Blanco JG; González Font AE; Córdova Hurtado LP; Castañeda VL; Fierro IV; Romero LP; Reyes HA
Pharmacogenet Genomics; 2021 Jul; 31(5):108-115. PubMed ID: 34096893
[TBL] [Abstract][Full Text] [Related]
30. A systematic review of the protective effects of silymarin/silibinin against doxorubicin-induced cardiotoxicity.
Singh M; Kadhim MM; Turki Jalil A; Oudah SK; Aminov Z; Alsaikhan F; Jawhar ZH; Ramírez-Coronel AA; Farhood B
Cancer Cell Int; 2023 May; 23(1):88. PubMed ID: 37165384
[TBL] [Abstract][Full Text] [Related]
31. Early Diagnosis of Cardiotoxicity in Patients Undergoing Chemotherapy for Acute Lymphoblastic Leukemia.
Militaru A; Zus S; Cimpean AM; Iurciuc S; Matusz P; Iurciuc M; Lighezan D; Militaru M
Anticancer Res; 2019 Jun; 39(6):3255-3264. PubMed ID: 31177176
[TBL] [Abstract][Full Text] [Related]
32. Modern Management of Anthracycline-Induced Cardiotoxicity in Lymphoma Patients: Low Occurrence of Cardiotoxicity with Comprehensive Assessment and Tailored Substitution by Nonpegylated Liposomal Doxorubicin.
Olivieri J; Perna GP; Bocci C; Montevecchi C; Olivieri A; Leoni P; Gini G
Oncologist; 2017 Apr; 22(4):422-431. PubMed ID: 28275118
[TBL] [Abstract][Full Text] [Related]
33. The effect of dexrazoxane on myocardial injury in doxorubicin-treated children with acute lymphoblastic leukemia.
Lipshultz SE; Rifai N; Dalton VM; Levy DE; Silverman LB; Lipsitz SR; Colan SD; Asselin BL; Barr RD; Clavell LA; Hurwitz CA; Moghrabi A; Samson Y; Schorin MA; Gelber RD; Sallan SE
N Engl J Med; 2004 Jul; 351(2):145-53. PubMed ID: 15247354
[TBL] [Abstract][Full Text] [Related]
34. Early myocardial injury in children on doxorubicin for cancer chemotherapy: a cross-sectional study in a tertiary referral centre in Kenya.
Kariuki N; Kimani E; Jowi C; Wamalwa D; Suen JY; Fraser JF; Obonyo NG
BMC Cardiovasc Disord; 2024 May; 24(1):260. PubMed ID: 38769516
[TBL] [Abstract][Full Text] [Related]
35. Serum carnitine levels during the doxorubicin therapy. Its role in cardiotoxicity.
Yaris N; Ceviz N; Coskun T; Akytüz C; Büyükpamukçu M
J Exp Clin Cancer Res; 2002 Jun; 21(2):165-70. PubMed ID: 12148572
[TBL] [Abstract][Full Text] [Related]
36. Long-acting PDE5 inhibitor tadalafil prevents early doxorubicin-induced left ventricle diastolic dysfunction in juvenile mice: potential role of cytoskeletal proteins.
Nagiub M; Filippone S; Durrant D; Das A; Kukreja RC
Can J Physiol Pharmacol; 2017 Mar; 95(3):295-304. PubMed ID: 28238269
[TBL] [Abstract][Full Text] [Related]
37. Myocardial performance index and biochemical markers for early detection of doxorubicin-induced cardiotoxicity in children with acute lymphoblastic leukaemia.
Ruggiero A; De Rosa G; Rizzo D; Leo A; Maurizi P; De Nisco A; Vendittelli F; Zuppi C; Mordente A; Riccardi R
Int J Clin Oncol; 2013 Oct; 18(5):927-33. PubMed ID: 22911020
[TBL] [Abstract][Full Text] [Related]
38. Relationship between cumulative anthracycline dose and late cardiotoxicity in childhood acute lymphoblastic leukemia.
Nysom K; Holm K; Lipsitz SR; Mone SM; Colan SD; Orav EJ; Sallan SE; Olsen JH; Hertz H; Jacobsen JR; Lipshultz SE
J Clin Oncol; 1998 Feb; 16(2):545-50. PubMed ID: 9469339
[TBL] [Abstract][Full Text] [Related]
39. Predictive value of cardiac troponin T in pediatric patients at risk for myocardial injury.
Lipshultz SE; Rifai N; Sallan SE; Lipsitz SR; Dalton V; Sacks DB; Ottlinger ME
Circulation; 1997 Oct; 96(8):2641-8. PubMed ID: 9355905
[TBL] [Abstract][Full Text] [Related]
40. Acute and late toxicities of pirarubicin in the treatment of childhood acute lymphoblastic leukemia: results from a clinical trial by the Japan Association of Childhood Leukemia Study.
Hori H; Kudoh T; Nishimura S; Oda M; Yoshida M; Hara J; Tawa A; Usami I; Tanizawa A; Yumura-Yagi K; Kato K; Kobayashi R; Komada Y; Matsuo K; Horibe K;
Int J Clin Oncol; 2017 Apr; 22(2):387-396. PubMed ID: 27858183
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
